Organon’s Juliana Papa Drinane acquires 3,626 shares

Available on EDGAR 11/10/2026 - 04:08 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Organon & Co. reported that its Head of Mfg & Supply, Juliana Papa Drinane, exercised 3,626 restricted stock units on November 7, 2026, receiving 3,626 common shares. Each RSU represented a contingent right to one common share; 10,876 RSUs granted November 7, 2023, vested one-third each year, with final vesting on November 7, 2026. The transaction also reported 1,242 shares delivered or withheld for payment of exercise price or tax liability; the reported price was $13.87 per share. The derivative position shows zero RSUs following the transaction. No Rule 10b5-1 plan is reported.

Insider Trade Summary

3,626 shares exercised/converted

Exercise 3 txns

Insider Drinane Juliana Papa

Role Head of Mfg & Supply

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	3,626	$0.00	$0.00
Exercise	Common Stock	3,626	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,242	$13.87	$17K

Holdings After Transaction: Restricted Stock Units — 0 units (Direct); Common Stock — 20,858.703 shares (Direct)

Holdings Before and After: Restricted Stock Units, 3,626 to 0 units (Direct); Common Stock, 18,474.703 to 20,858.703 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Organon & Co.
2. F2. 10,876 RSUs were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.

Key Figures

Restricted stock units exercised: 3,626 RSUs Common shares acquired: 3,626 shares Shares delivered or withheld: 1,242 shares +4 more

7 metrics

Restricted stock units exercised 3,626 RSUs November 7, 2026

Common shares acquired 3,626 shares November 7, 2026

Shares delivered or withheld 1,242 shares For payment of exercise price or tax liability

Reported price per share $13.87 per share Shares delivered or withheld for payment of exercise price or tax liability

RSUs granted 10,876 RSUs Granted November 7, 2023

Annual vesting One-third of the grant Each year; final vesting date November 7, 2026

RSUs following transaction 0 RSUs Reported derivative position after the November 7, 2026 transaction

Key Terms

restricted stock unit (RSU), contingent right, vesting

3 terms

restricted stock unit (RSU) financial

"Each restricted stock unit ("RSU") represents a contingent right"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

contingent right technical

"represents a contingent right to receive one share"

vesting financial

"one-third vest each year"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OGN shares did Juliana Papa Drinane acquire from RSUs?

Juliana Papa Drinane acquired 3,626 OGN common shares when 3,626 restricted stock units were exercised on November 7, 2026. Each RSU represented a contingent right to one common share. The 10,876 RSUs granted on November 7, 2023, vested one-third each year, with the final vesting date on November 7, 2026.

How many OGN shares were delivered or withheld for exercise-price or tax-liability payment?

1,242 common shares were delivered or withheld for payment of exercise price or tax liability, at a reported price of $13.87 per share. This was reported separately from the 3,626 restricted stock units exercised and the 3,626 common shares acquired.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Drinane Juliana Papa

(Last) (First) (Middle)

C/O ORGANON &CO.

30 HUDSON STREET, FLOOR 33

(Street)

JERSEY CITY NEW JERSEY 07302

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Mfg & Supply

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2026		M		3,626	A	$0	22,100.703	D
Common Stock	11/07/2026		F		1,242	D	$13.87	20,858.703	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	11/07/2026		M			3,626	11/07/2025(2)	11/07/2026	Common Stock	3,626	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Organon & Co.

2. 10,876 RSUs were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.

Remarks:

	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)